Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD)

被引：0

作者：

van Son, Koen C. ^{[1
,2
,3
]}

van Dijk, Anne-Marieke ^{[1
,2
]}

Driessen, Stan ^{[1
,2
]}

Mak, Anne Linde ^{[1
]}

Witjes, Julia J. ^{[1
]}

Houttu, Veera A. T. ^{[1
]}

Zwirs, Diona ^{[1
]}

Nieuwdorp, Max ^{[1
]}

van den Born, Bert-Jan H. ^{[1
,4
]}

Fischer, Johan C. ^{[5
]}

Tushuizen, Maarten E. ^{[6
]}

Drenth, Joost P. H. ^{[3
]}

Hamer, Henrike M. ^{[5
]}

Beuers, Ulrich H. W. ^{[3
]}

Verheij, Joanne ^{[2
,7
]}

Holleboom, Adriaan Georgius ^{[1
]}

机构：

[1] Amsterdam UMC, Locat AMC, Dept Vasc Med, Meibergdreef 9, Amsterdam, Netherlands

[2] Amsterdam Gastroenterol Endocrinol Metab AGEM Inst, Amsterdam UMC, Locat AMC, Amsterdam, Netherlands

[3] Amsterdam UMC, Dept Gastroenterol & Hepatol, Locat AMC, Meibergdreef 9, Amsterdam, Netherlands

[4] Dept Publ & Occupat Hlth, Amsterdam UMC, Locat AMC, Amsterdam, Netherlands

[5] Univ Amsterdam, Dept Lab Med, Lab Specialized Diagnost & Res, Amsterdam UMC, Amsterdam, Netherlands

[6] Dept Gastroenterol & Hepatol, LUMC, Leiden, Netherlands

[7] Amsterdam UMC, Locat AMC, Dept Pathol, Amsterdam, Netherlands

来源：

CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2024年 / 62卷 / 11期

关键词：

metabolic dysfunction-associated steatotic liver disease (MASLD); advanced liver fibrosis; enhanced liver fibrosis (ELF)-test; reflex testing; diagnostic algorithms;

D O I：

10.1515/cclm-2024-0470

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：e236 / e239

页数：4

共 50 条

[31] Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Ramanathan, Raghu
Patwa, Sohum A.
Ali, Ahmad Hassan
Ibdah, Jamal A.
CELLS, 2023, 12 (24)
[32] Metabolic dysfunction-associated steatotic liver disease and the heart
Driessen, Stan
Francque, Sven M.
Anker, Stefan D.
Cabezas, Manuel Castro
Grobbee, Diederick E.
Tushuizen, Maarten E.
Holleboom, Adriaan G.
HEPATOLOGY, 2023,
[33] Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
Stefan, Norbert
Roden, Michael
DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 : S290 - S296
[34] Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
Orfanidou, Myrsini
Polyzos, Stergios A.
MEDICINA-LITHUANIA, 2025, 61 (01):
[35] Metabolic dysfunction-associated steatotic liver disease and atherosclerosis
Castillo-Nunez, Yulino
Almeda-Valdes, Paloma
Gonzalez-Galvez, Guillermo
Arechavaleta-Granell, Maria del Rosario
CURRENT DIABETES REPORTS, 2024, 24 (07) : 158 - 166
[36] Metabolic dysfunction-associated steatotic liver disease in adults
Huang, Daniel Q.
Wong, Vincent W. S.
Rinella, Mary E.
Boursier, Jerome
Lazarus, Jeffrey V.
Yki-Jarvinen, Hannele
Loomba, Rohit
NATURE REVIEWS DISEASE PRIMERS, 2025, 11 (01):
[37] Evaluation of metabolic dysfunction-associated steatotic liver disease (MASLD) terminology in different clinical settings
Iruzubieta, Paula
Santos-Laso, Alvaro
Arias-Loste, Maria Teresa
Calleja, Jose Luis
Crespo, Javier
JOURNAL OF HEPATOLOGY, 2024, 80 (03) : e121 - e123
[38] Converging Pathways between Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Diabetes in Children
Faienza, Maria Felicia
Farella, Ilaria
Khalil, Mohamad
Portincasa, Piero
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (18)
[39] Metabolic dysfunction-associated steatotic liver disease in children
Goyal, Nidhi P.
Xanthakos, Stavra
Schwimmer, Jeffrey B.
GUT, 2025,
[40] Menopause and metabolic dysfunction-associated steatotic liver disease
Polyzos, Stergios A.
Goulis, Dimitrios G.
MATURITAS, 2024, 186

← 1 2 3 4 5 →